Dean M Najarian (Dean Najarian)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Bariatric Surgery

Platelet Rich Plasma

Bipolar Disorder

Top Venues

Neuropsychiatric disease and treatment

Janssen Scientific Affairs LLC

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Janssen Scientific Affairs LLC Apr 01 2003

United States

Associate Field Director, Neuroscience :: Medical affairs

Publications

Ruth Milz, Carmela Benson, Karl Knight, José Antunes, Dean M Najarian, Paola-Maria Lopez Rengel, Steven Wang, Ute Richarz, Srihari Gopal, John M Kane
The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia. Neuropsychiatric disease and treatment 19 (2023)
Ruth Milz, Carmela Benson, Karl Knight, José Antunes, Dean M Najarian, Paola-Maria Lopez Rengel, Steven Wang, Ute Richarz, Srihari Gopal, John M Kane
The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia. Neuropsychiatric disease and treatment 19 (2023)
Ibrahim Turkoz, Mehmet Daskiran, H Lynn Starr, Dean M Najarian, Oliver Lopena, Camilo Obando, Alexander Keenan, Carmela Benson, Srihari Gopal
Comparing Relapse Rates in Real-World Patients with Schizophrenia Who Were Adequately versus Not Adequately Treated with Paliperidone Palmitate Once-Monthly Injections Before Transitioning to Once-Every-3-Months Injections. Neuropsychiatric disease and treatment 18 (2022)
Christoph U Correll, Jennifer Kern Sliwa, Dean M Najarian, Stephen R Saklad
Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics. CNS spectrums 24 (4) (2018)